−19.418 BRL
−1.46 B BRL
6.09 B BRL
60.33 M
About ARGENX SE
Sector
CEO
Tim van Hauwermeiren
Headquarters
Amsterdam
Website
Founded
2008
ISIN
BRA1RGBDR004
FIGI
BBG00XX9HGJ7
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where A1RG34 is featured.